Searched for
CIPLA SUPPLIES TO US
Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Q4 earnings, crude oil, FII action among 8 factors to steer D-Street this weekIndian stock markets are set for a busy week. Key events like Q4 earnings announcements for many companies will influence trading. Foreign ...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Cipla recalls over 400 cartons of cancer drug in US: FDACipla USA is recalling over 400 cartons of its anti-cancer drug Nilotinib Capsules. The recall is due to a manufacturing issue where the ca...
- Cipla shares slide 5% after temporary halt in key drug manufacturingCipla shares fell sharply on Friday after a halt in Lanreotide Injection production due to USFDA observations at its Greek partner. Supply ...
- Cipla sees no major impact on biz from Donald Trump admin's decision to pause foreign aid: Umang VohraCipla, a drugmaker involved in supplying HIV medications through US-supported programmes, anticipates minimal impact from the Trump adminis...
- Cipla expects to commence supplies to US from China plant later this yearCipla plans to start supplying from its China facility to the US market by the second half of the current fiscal year, following USFDA appr...
- Cipla says supply of COVID-19 drug remdesivir catching up with demandBackorders and complaints over low supply started moderating in the second week of May, the drugmaker said, after it began ramping up produ...
- Analysts bet on Cipla as acquisitions expected to boost company's growthAcquisitions of two companies in the US will help Cipla increase its foothold in the market and has made analysts bullish on the counter.
- Cipla awarded $188.95 million tender by Global Fund for ARV drugs to treat HIV/AIDSCipla has been awarded $188.95 million tender for anti-retrovirals drugs by Global Fund which would enable it to supply the medicines to ov...
- Cipla in talks to supply drugs to Germany’s BIBoehringer Ingelheim in talks with Cipla for supply of generic drugs to the $17-bn German coa for two drugs.
- Adcock's plan to buy Medpro hits Cipla hurdleSouth African company Adcock Ingram's plans to buy Cipla Medpro, with whom Cipla has a 20-year drug-supply agreement, has run into trouble ...
- Reliance, Cipla in talks for retail pactIf the deal is sealed, Cipla will supply generic pharmaceutical products to Reliance Retail.
Load More
